Early Knee Osteoarthritis Management and Assessment

Early knee osteoarthritis (OA) signifies a stage at which structural changes within the joint are minimal and clinical symptoms may be subtle, yet represent a key window for interventions to alter disease trajectory. Assessment relies on a combination of clinical evaluation—focusing on joint pain, stiffness, functional limitations and prodromal symptoms—and advanced imaging modalities. Magnetic resonance imaging (MRI) reveals cartilage integrity, bone marrow lesions, meniscal pathology and synovial inflammation prior to radiographic changes. Biochemical biomarkers in serum and synovial fluid, reflecting cartilage turnover, subchondral bone remodelling and inflammatory processes, offer potential for risk stratification. Management strategies aim to reduce joint load, improve musculoskeletal health and modulate early inflammatory activity. Non-pharmacological approaches, including tailored exercise regimens, weight management and neuromuscular training, constitute first-line therapy. Pharmacological agents focus on symptom relief and, in experimental settings, disease-modifying osteoarthritis drugs to preserve joint structure. Early identification of at-risk individuals, guided by alignment and morphological risk factors such as tibial slope and dynamic loading patterns, underpins a precision medicine approach. Multidisciplinary care pathways integrate patient education, physiotherapy, nutritional advice and emerging regenerative techniques to forestall progression to established OA, reduce disability and enhance long-term joint health.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Early Knee Osteoarthritis Management and Assessment publication trend

The graph below shows the total number of articles in early knee osteoarthritis management and assessment across all publications each year (not limited to Nature Index journals).

Technical terms

Bone marrow lesion (BML): Focal subchondral bone changes visible on MRI indicating microdamage and inflammation.

Effusion-synovitis: Accumulation of synovial fluid and synovial membrane inflammation detectable by MRI.

Kellgren–Lawrence grade: Radiographic classification scale for osteoarthritis severity from 0 (none) to 4 (severe).

Meniscal extrusion: Displacement of the meniscus beyond the tibial margin, altering load transmission.

Biochemical biomarker: Measurable substance in body fluids reflecting joint tissue metabolism or inflammation.

References

1. Greater medial proximal tibial slope is associated with bone marrow lesions in middle-aged women with early knee osteoarthritis. Journal of Orthopaedics and Traumatology (2023).
2. Risk factors and the natural history of accelerated knee osteoarthritis: a narrative review. BMC Musculoskeletal Disorders (2020).
3. Early diagnosis to enable early treatment of pre-osteoarthritis. Arthritis Research & Therapy (2012).
4. Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis. Arthritis Research & Therapy (2011).